ClinicalTrials.gov record
Enrolling by invitation Phase 3 Interventional

ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study

ClinicalTrials.gov ID: NCT06194799

Public ClinicalTrials.gov record NCT06194799. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 8:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 52-Week, Open-Label Extension Study of ACP-204 in Adults With Alzheimer's Disease Psychosis

Study identification

NCT ID
NCT06194799
Recruitment status
Enrolling by invitation
Study type
Interventional
Phase
Phase 3
Lead sponsor
ACADIA Pharmaceuticals Inc.
Industry
Enrollment
752 participants

Conditions and interventions

Interventions

  • ACP-204 Drug

Drug

Eligibility (public fields only)

Age range
55 Years to 95 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 22, 2024
Primary completion
Mar 31, 2029
Completion
Apr 30, 2029
Last update posted
May 3, 2026

2024 – 2029

United States locations

U.S. sites
19
U.S. states
4
U.S. cities
9
Facility City State ZIP Site status
ATP Clinical Research Costa Mesa California 92626
Neuro-Pain Medical Center Fresno California 93710
New Life Medical Research Center Hialeah Florida 33012
Reliable Clinical Research LLC Hialeah Florida 33012
Homestead Associates in Research Inc. Miami Florida 33032
Premier Clinical Research Institute Inc Miami Florida 33122
Advanced Clinical Research Miami Florida 33135
Verus Clinical Research Miami Florida 33135
Quantum Clinical Trials Miami Florida 33140
Future Care Solution, LLC Miami Florida 33165
MediClear Medical & Research Center, Inc. Miami Florida 33165
ABBA Medical Research LLC Miami Florida 33176
New Med Research Miami Gardens Florida 33056
Floridian Neuroscience Institute Miami Lakes Florida 33016
Abington Neurological Associates Abington Pennsylvania 19001
Horizon Clinical Research Group Cypress Texas 77429
Uni Texas Health Science Center Houston Texas 77054
Clinical Trial Network LLC Houston Texas 77074
Kaleidoscope Clinical Research Houston Texas 77089

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 50 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06194799, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 3, 2026 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06194799 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →